Shanghai Longwood Biopharmaceuticals Co., Ltd.

Savant Technologies LLC

Emc IP Holding Company LLC

Shanghai Huali Microelectronics Corporation

Doncero (shanghai) Industrial Co., Ltd.

Savant Technoloiges LLC

Zhe Wang

Jie Gao

Li Jiang

Kun Xiao

Jing Chen

Hai Huang

Zhihong Zeng

Jiachen Yang

Sai Yang

Xiaoguang Wang

Guoqin Fan

Min Zhang

Lei Deng

Pan Yao

Jingxun Fang

Guifeng Tang

Jing Wen

Wei Zuo

Zhongyi Yang

Chuanmin Zhang

Rongzhen Jiang

Xiaogang Tong

Xiaodong Tian

Cenbin Lu

Lamp housing

Techniques for error detection involve injecting, to a switch of a storage system, information representing an error of at least one device to be tested of the system, such that the information representing the error is passed from an upstream port of the switch to a computing device connected with the switch, the switch being connected to the at least one device to be tested via a downstream port. The techniques further involve obtaining a handling result of the computing device on the information representing the error, and determining an error handling capability of the system at least partly by analyzing the handling result. Accordingly, slave storage devices of storage system nodes, connectors, the entire PCIe topology at the CPU level, and an NVMe bus can be tested, so that the entire logical path of the error handling can be tested, thereby improving performance and saving testing costs.

Methods, electronic devices, storage systems, and computer program products for error detection

The present invention relates to a bicyclic nucleocapsid inhibitor and the use of the same as a drug in the treatment of hepatitis B. In particular, disclosed is a compound having a structure shown by the following formula (A1): or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt, a hydrate, or a solvate thereof, that can be used as an HBV inhibitor, wherein the definition of each group is as described in detail in the description. The present invention also relates to a pharmaceutical composition comprising the compound and the use of the same in the treatment of hepatitis B.

Substituted pyrrolizines for the treatment of hepatitis B

Provided is a selective JAK kinase selective inhibitor and a preparation method and the use thereof. In particular, provided is a compound having the structure as shown in chemical formula (I) as a JAK kinase inhibitor or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt, a hydrate or a solvate thereof. 

JAK kinase inhibitor and preparation method and use thereof

Provided is a switchable Correlated Color Temperature (CCT) illuminating device. The device may include a CCT switching unit, forming electrical connection with a drive power source, and a bulb shell, at least one filament being arranged inside the bulb shell, the filament including a substrate, and a first light-emitting unit group and a second light-emitting unit group arranged on the substrate and forming electrical connection with the CCT switching unit. Each of the first light-emitting unit group and the second light-emitting unit group comprises one or more light-emitting unit, the first light-emitting unit group and the second light-emitting unit group are connected in parallel and conducting directions thereof are opposite, and when one of the first light-emitting unit group and the second light-emitting unit group is in a positive ON status, the other is in a negative OFF status. When the CCT switching unit is in a first operating mode, the first light-emitting unit group is in the positive ON status, and the CCT switchable illuminating device emits light with a first CCT. When the CCT switching unit is in a second operating mode, the second light-emitting unit group is in electrical conduction, and the CCT switchable illuminating device emits light with a second CCT. Therefore, the problem that the illuminating device in the prior art has a single CCT is solved.

CCT switchable illuminating device

Provided in the present application are a sulfonyl amidine as represented by formula (I) as an indoleamine-2,3-dioxygenase inhibitor, and a preparation method therefor and the use thereof. The compound of formula (I) in the present application can be used as an indoleamine-2,3-dioxygenase inhibitor in the preparation of a drug for preventing and/or treating indoleamine-2,3-dioxygenase-mediated diseases. 

Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof

The present invention relates to an MDM2 inhabitor, a preparation method therefor, a pharmaceutical composition thereof, and the use thereof specifically, the present invention relates to a compound represented by formula I. The compound has excellent MDM2 inhibitory activities, and can be used for preparing a pharmaceutical composition for treating cancers and other diseases related to MDM2 activities, particularly p53 wild-type cancer. 

MDM2 inhibitor, preparation method therefor, pharmaceutical composition thereof and use thereof

An angle ruler includes a ruler, a ruler holder and a digital display module, the digital display module is fixed on the ruler holder and the ruler holder has an inclined edge. The angle ruler can not only retain the using habit of the user, but also can make the reading more convenient, accurate and time-saving.

Angle ruler

Disclosed are an endocyclic thiamidinoamide-arylamide compound and a pharmaceutical composition comprising the compound described above, and the use of the compound or pharmaceutical composition in the treatment of hepatitis B. In particular, disclosed is a compound that can be used as an HBV replication inhibitor and has the structure as shown in chemical formula (L), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt, hydrate or solvate thereof. 

Endocyclic thiamidinoamide-arylamide compound and use thereof for treating hepatitis B

A fabrication method for improving surface planarity after tungsten chemical mechanical polishing (W-CMP) is disclosed. The method forms contact holes and dummy patterns by performing two respective photolithography-and-etching processes to ensure that the dummy patterns have a depth smaller than that of the contact holes. Then the method fills tungsten into the contact holes and dummy patterns and removes the redundant tungsten by a W-CMP process. With such a method, difference of wiring density between areas can be reduced by the dummy patterns, and hence a better surface planarity of the contact hole layer can be achieved. Besides, as the dummy patterns are formed in a pre-metal dielectric layer and their depth is well controlled, tungsten filled in the dummy patterns will not contact with the device area below the pre-metal dielectric layer, and thus will not affect the performance of the device.

Fabrication method for improving surface planarity after tungsten chemical mechanical polishing

Growing community of inventors

Shanghai, China

Zhe Wang